These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 29100781)

  • 1. Estrogens and female liver health.
    Chen KL; Madak-Erdogan Z
    Steroids; 2018 May; 133():38-43. PubMed ID: 29100781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiota and butyrate contribute to nonalcoholic fatty liver disease in premenopause due to estrogen deficiency.
    Liu L; Fu Q; Li T; Shao K; Zhu X; Cong Y; Zhao X
    PLoS One; 2022; 17(2):e0262855. PubMed ID: 35108315
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota: Association with NAFLD and Metabolic Disturbances.
    Lau E; Carvalho D; Freitas P
    Biomed Res Int; 2015; 2015():979515. PubMed ID: 26090468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Menopause and Non-Alcoholic Fatty Liver Disease: A Review Focusing on Therapeutic Perspectives.
    Venetsanaki V; Polyzos SA
    Curr Vasc Pharmacol; 2019; 17(6):546-555. PubMed ID: 29992886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Navigating nonalcoholic fatty liver disease (NAFLD): Exploring the roles of estrogens, pharmacological and medical interventions, and life style.
    Zuo Q; Park NH; Lee JK; Santaliz-Casiano A; Madak-Erdogan Z
    Steroids; 2024 Mar; 203():109330. PubMed ID: 37923152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gut-liver axis, nutrition, and non-alcoholic fatty liver disease.
    Kirpich IA; Marsano LS; McClain CJ
    Clin Biochem; 2015 Sep; 48(13-14):923-30. PubMed ID: 26151226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal hormones, gut microbiota and non-alcoholic fatty liver disease.
    Koukias N; Buzzetti E; Tsochatzis EA
    Minerva Endocrinol; 2017 Jun; 42(2):184-194. PubMed ID: 27879962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex Differences in Nonalcoholic Fatty Liver Disease: Estrogen Influence on the Liver-Adipose Tissue Crosstalk.
    Morán-Costoya A; Proenza AM; Gianotti M; Lladó I; Valle A
    Antioxid Redox Signal; 2021 Sep; 35(9):753-774. PubMed ID: 33736456
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Estrogens in the Regulation of Liver Lipid Metabolism.
    Palmisano BT; Zhu L; Stafford JM
    Adv Exp Med Biol; 2017; 1043():227-256. PubMed ID: 29224098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
    Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
    J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-Alcoholic Fatty Liver Disease and Extra-Hepatic Cancers.
    Sanna C; Rosso C; Marietti M; Bugianesi E
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Metabolic Role of Gut Microbiota in the Development of Nonalcoholic Fatty Liver Disease and Cardiovascular Disease.
    Sanduzzi Zamparelli M; Compare D; Coccoli P; Rocco A; Nardone OM; Marrone G; Gasbarrini A; Grieco A; Nardone G; Miele L
    Int J Mol Sci; 2016 Jul; 17(8):. PubMed ID: 27483246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopause.
    Robeva R; Mladenović D; Vesković M; Hrnčić D; Bjekić-Macut J; Stanojlović O; Livadas S; Yildiz BO; Macut D
    Maturitas; 2021 Sep; 151():22-30. PubMed ID: 34446275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Obesity, fatty liver disease and intestinal microbiota.
    Arslan N
    World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gut microbiota manipulation with prebiotics in patients with non-alcoholic fatty liver disease: a randomized controlled trial protocol.
    Lambert JE; Parnell JA; Eksteen B; Raman M; Bomhof MR; Rioux KP; Madsen KL; Reimer RA
    BMC Gastroenterol; 2015 Dec; 15():169. PubMed ID: 26635079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.
    Della Torre S
    Front Endocrinol (Lausanne); 2020; 11():572490. PubMed ID: 33071979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estrogen-gut microbiome axis: Physiological and clinical implications.
    Baker JM; Al-Nakkash L; Herbst-Kralovetz MM
    Maturitas; 2017 Sep; 103():45-53. PubMed ID: 28778332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pediatric non-alcoholic fatty liver disease: Recent solutions, unresolved issues, and future research directions.
    Clemente MG; Mandato C; Poeta M; Vajro P
    World J Gastroenterol; 2016 Sep; 22(36):8078-93. PubMed ID: 27688650
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut microbiota-mediated generation of saturated fatty acids elicits inflammation in the liver in murine high-fat diet-induced steatohepatitis.
    Yamada S; Kamada N; Amiya T; Nakamoto N; Nakaoka T; Kimura M; Saito Y; Ejima C; Kanai T; Saito H
    BMC Gastroenterol; 2017 Nov; 17(1):136. PubMed ID: 29187142
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.